Shanghai Sailun Biotechnology Co., Ltd
Initial public offering and listing on the science and Innovation Board
Issuance announcement
Sponsor (lead underwriter): Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd
Scan QR code to view the full text of the announcement
Important tips
Shanghai Sailun Biotechnology Co., Ltd. (hereinafter referred to as "Sailun biotechnology", "issuer" or "company") in accordance with the implementation opinions on establishing a science and innovation board and pilot registration system in Shanghai Stock Exchange (CSRC announcement [2019] No. 2) issued by China Securities Regulatory Commission (hereinafter referred to as "CSRC" and "CSRC") Measures for the administration of securities issuance and underwriting (CSRC order [No. 144]) (hereinafter referred to as the "administrative measures"), measures for the administration of the registration of initial public offering of shares on the science and Innovation Board (for Trial Implementation) (CSRC order [No. 174]), The measures for the implementation of the issuance and underwriting of shares on the science and Innovation Board of Shanghai Stock Exchange (SZF [2021] No. 76) (hereinafter referred to as the "implementation measures") promulgated by the Shanghai Stock Exchange (hereinafter referred to as the "Shanghai Stock Exchange") Guidelines for the application of the issuance and underwriting rules of the science and Innovation Board of Shanghai Stock Exchange No. 1 - initial public offering of shares (SZF [2021] No. 77) (hereinafter referred to as the "underwriting guidelines"), detailed rules for the implementation of online issuance of initial public offering shares in Shanghai market (SZF [2018] No. 40) (hereinafter referred to as the "detailed rules for the implementation of online issuance") Detailed rules for the implementation of offline issuance of initial public offerings in Shanghai market (SZF [2018] No. 41) (hereinafter referred to as "detailed rules for the implementation of offline issuance"), the code for underwriting initial public offerings under the registration system issued by the China Securities Association (zsxf [2021] No. 213) Detailed rules for the administration of offline investors in initial public offerings (zxsf [2018] No. 142), rules for the administration of offline investors in initial public offerings under the registration system and guidelines for the classification, evaluation and management of offline investors in initial public offerings under the registration system (zxsf [2021] No. 212), etc, And the relevant provisions of the Shanghai Stock Exchange on stock issuance and listing rules and the latest operating guidelines, such as initial public offering of shares and listing on the science and innovation board.
Founder Securities Co.Ltd(601901) underwriting sponsor Co., Ltd. (hereinafter referred to as "founder sponsor" or "sponsor (lead underwriter)") serves as the sponsor (lead underwriter) of this offering.
This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as "strategic placement"), offline inquiry placement to qualified investors (hereinafter referred to as "offline issuance"), and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts market value in Shanghai market (hereinafter referred to as "online issuance"). The strategic placement, preliminary inquiry and online and offline issuance of this offering shall be organized and implemented by the founder sponsor of the sponsor (lead underwriter). The strategic placement of this offering is carried out at the sponsor (lead underwriter). The preliminary inquiry and offline subscription are carried out through the IPO offline subscription electronic platform of Shanghai Stock Exchange (hereinafter referred to as "offline subscription platform"), and the online offering is carried out through the trading system of Shanghai Stock Exchange. Please read this announcement carefully. Please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) for details of preliminary inquiry and electronic offline issuance The detailed rules for the implementation of offline issuance and other relevant provisions.
Investors can visit the following website（ http://www.sse.com.cn./disclosure/listedinfo/listing/ 、 http://www.sse.com.cn./ipo/home/ ）Check the full text of the announcement.
Basic information of the issuer
The full name of the company is Shanghai Salem biotechnology securities, or Salem biotechnology for short
limited company
Securities code / offline subscription 688163 online subscription code 787163
code
Offline subscription referred to as Salem biological online subscription referred to as Salem subscription
Basic information of this offering
Offline preliminary inquiry direct
The pricing method determines the issue price, and the number of offline issues (27.06 million)
No more cumulative bidding (shares)
inquiry
Total share capital after issuance (10000 shares in total)
25.00 shares) after 10822.00 lines
（%）
High price rejection ratio (%) 1.0096, whichever is lower (yuan / share) 33.0380
The issue price (yuan / issue price)
(shares) 33.03 exceeds the lower of the four numbers, take no
And exceeding range (%)
P / E ratio of issuance (earnings per share in 2020)
Audit deduction and other non recurring valuation indicators (if applicable)
63.28 before and after profit and loss, whichever is lower ([indicate that the calculation port is not applicable
Attributable to shareholders of the parent company (])
Net profit divided by total share capital after the issuance)
Industry name and industry pharmaceutical manufacturing (C27) industry T-3 static 35.24
Industry code industry P / E ratio
Determined according to the issue price
Committed subscription strategy allocation 121.1020 committed subscription strategy allocation 4.48
Total sales (10000 shares) accounting for the proportion of total sales in this offering
Quantity ratio (%)
Strategic placement callback website 1813.6980 strategic placement callback website 771.20
Lower issue quantity (10000 shares) upper issue quantity (10000 shares)
Number of proposed offline subscriptions
Maximum amount (10000 shares) (application 900) proposed offline subscription of 100
The purchase quantity shall be the lower limit of 100000 shares (10000 shares)
Integer multiple) number of proposed online subscriptions
Maximum amount (10000 shares) (0.75 for application) brokerage commission for placement of new shares 0.5
The number of shares purchased shall be 500 shares at the whole rate (%)
(several times) according to the issuing price
The calculated estimated raised capital is 89379.18 underwriting method, and the balance is underwritten
Total amount (10000 yuan)
Important date of this issuance
Offline Subscription Date and from to February 28, 2022 (t online subscription date and from to February 28, 2022 (t time day) 9:30-15:00 time day) 9:30-11:30,
13:00-15:00
Offline payment date and end of March 2, 2022 (T + 2 online payment date and end of 16:00 on March 2, 2022 (T + 2 time date))
Remarks: 1 "The lower of the four numbers" refers to the lower of the median and weighted average of the remaining quotations of offline investors after excluding the highest quotation, as well as the median and weighted average of the remaining quotations of public offering products, social security funds and pensions.
The issuer and the recommendation institution (lead underwriter) solemnly remind the majority of investors to pay attention to investment risks and invest rationally, carefully read this announcement and publish it in Shanghai Securities News and China Securities News on February 25, 2022 (t-1) Special announcement on investment risk of Shanghai Sailun Biotechnology Co., Ltd. in its initial public offering and listing on the science and Innovation Board (hereinafter referred to as "special announcement on investment risk") in the securities times and Securities Daily.
This announcement is only a brief description of the issue of shares and does not constitute investment suggestions. Investors who want to know the details of this offering, please read it carefully and publish it on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on February 18, 2022 (T-6) The letter of intent of Shanghai Sailun Biotechnology Co., Ltd. for initial public offering and listing on the science and Innovation Board (hereinafter referred to as the "letter of intent"). The issuer and the recommendation institution (lead underwriter) hereby remind investors to pay special attention to the chapters of "tips on major matters" and "risk factors" in the prospectus, fully understand the issuer's risk factors, judge its operation status and investment value by themselves, and make investment decisions prudently. The issuer's operating conditions may change due to the influence of politics, economy, industry and operation and management level, and the possible investment risks arising therefrom shall be borne by the investors themselves.
The listing of the shares will be announced separately. 1、 Preliminary inquiry results and pricing
The application of Shanghai Sailun Biotechnology Co., Ltd. for the initial public offering of RMB common shares (A shares) and listing on the science and Innovation Board (hereinafter referred to as "this offering") has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange, and has been registered by CSRC Huitong Yi (CSRC license [2022] No. 204). The issuer's stock is referred to as "Salem biology" for short, and the expanded stock is referred to as "Salem biology" for short. The stock code is "688163". This code is also used for the preliminary inquiry and offline subscription of this issuance. The online subscription code of this issuance is "787163". The issuance is carried out in a combination of strategic placement, offline issuance and online issuance.
(I) preliminary inquiry
1. Overall declaration
The initial inquiry period of this offering is 9:30-15:00 on February 23, 2022 (T-3). As of 15:00 on February 23, 2022 (T-3), the sponsor (lead underwriter) has received the preliminary inquiry and quotation information of 11165 placing objects managed by 449 offline investors through the offline subscription platform of Shanghai Stock Exchange, with the quotation range of 11.09 yuan / share - 50.50 yuan / share, and the total number of shares to be purchased is 8683640 million. For the specific quotation of the placing object, please refer to the "attached table: statistical table of investor quotation information" of this announcement.
2. Investor verification
According to the conditions for offline investors participating in the preliminary inquiry published in the announcement on the issuance arrangement and preliminary inquiry of Shanghai Sailun Biotechnology Co., Ltd. for initial public offering and listing on the science and Innovation Board (hereinafter referred to as the "announcement on issuance arrangement and preliminary inquiry") published on February 18, 2022 (T-6), and verified by the sponsor (lead underwriter), 14 placing objects managed by 5 offline investors failed to provide audit materials or materials as required, but failed to pass the qualification audit of the sponsor (lead underwriter); The two placing objects managed by the two offline investors belong to the scope of prohibited placing; The five placing objects managed by the two offline investors did not submit the pricing basis and suggested price or price range before the inquiry. The quotations of 21 placing objects managed by the above 9 offline investors have been determined to be invalid and eliminated, and the total number of shares to be purchased is 164.7 million. For details, please refer to the part marked as "invalid quotation" in the attached table "statistical table of investor quotation information".
After excluding the above invalid quotations, the 11144 placing objects managed by the remaining 446 offline investors all meet the conditions of offline investors specified in the announcement on issuance arrangement and preliminary inquiry. The quotation range is 11.09 yuan / share - 50.50 yuan / share, and the total number of shares to be purchased is 8667170 million.
(II) excluding the highest quotation
1. Elimination
After the issuer and the recommendation institution (lead underwriter) rank the purchase price from high to low according to the inquiry results after excluding the above invalid quotation, and calculate the cumulative total amount of proposed purchase corresponding to each price, the number of proposed purchase according to the placing object in the same purchase price from small to large, the same purchase price and the same number of proposed purchase according to the application time from late to early The same proposed purchase price, the same proposed purchase quantity and the same purchase time (the purchase time shall be subject to the records of the offline purchase platform of Shanghai Stock Exchange) shall be sorted from the bottom to the top according to the order of placing objects automatically generated by the offline purchase platform of Shanghai Stock Exchange. The purchase with the highest quotation in the total amount of proposed purchase shall be excluded, and the excluded amount of proposed purchase shall not be less than the qualified amount
